For a country of nearly 55 million people, consistent medicine access matters. Torque Pharma supports Myanmar with quality formulations across essential therapy areas. Each year, we increase our exports by 10%, addressing the growing healthcare challenges that prevent access to essential medicines.
As we expand our reach, Torque is expected to grow up to 15% annually, serving healthcare providers, distributors, and direct consumers. This sustained growth enables our medicines to reach more people in Myanmar each year, creating a healthier tomorrow.
With regulatory approval from Myanmar’s FDA and rigorous quality checks, Torque Pharma delivers safe medicines to millions.
Air freight reaches Myanmar in 7–10 days, while sea routes support large consignments, ensuring secure delivery and preserved quality.
Torque Pharma therapeutics cost up to 80% less than Western alternatives, expanding access while reducing costs.
WHO-GMP production meets standards, ensuring consistent quality, controlled manufacturing, and dependable supply.
